Is Buying Chemed Corporation (CHE) Here a Winning Strategy?

May 17, 2018 - By Michael Lara

Investors sentiment decreased to 0.96 in 2017 Q4. Its down 0.08, from 1.04 in 2017Q3. It dived, as 18 investors sold Chemed Corporation shares while 94 reduced holdings. 49 funds opened positions while 58 raised stakes. 14.86 million shares or 3.45% less from 15.40 million shares in 2017Q3 were reported.
Comerica National Bank stated it has 0.03% of its portfolio in Chemed Corporation (NYSE:CHE). The Iowa-based Iowa Bankshares has invested 0.21% in Chemed Corporation (NYSE:CHE). Oppenheimer Asset Management Incorporated reported 0.1% stake. The Maryland-based Proshare Advsrs Ltd Liability Com has invested 0% in Chemed Corporation (NYSE:CHE). Thrivent For Lutherans reported 90,846 shares. Ahl Partners Ltd Liability Partnership has invested 0.13% in Chemed Corporation (NYSE:CHE). Zebra Capital Mngmt Limited Com invested in 0.09% or 1,061 shares. Rockefeller Fin Services Incorporated stated it has 94,789 shares or 0.36% of all its holdings. Sivik Global Health Limited Liability Com reported 10,000 shares or 0.9% of all its holdings. Fdx Inc invested in 3,927 shares or 0.03% of the stock. Greenleaf Tru reported 226 shares. Martingale Asset Lp owns 28,703 shares or 0.09% of their US portfolio. Pub Employees Retirement System Of Ohio has 0% invested in Chemed Corporation (NYSE:CHE). Delta Mngmt Limited Liability Com accumulated 1,335 shares or 0.2% of the stock. Moreover, Investec Asset Mngmt Limited has 0.3% invested in Chemed Corporation (NYSE:CHE) for 295,657 shares.

Since January 12, 2018, it had 0 insider buys, and 13 sales for $27.86 million activity. LEE SPENCER S had sold 1,428 shares worth $428,257 on Wednesday, April 25. 22,000 Chemed Corporation (NYSE:CHE) shares with value of $6.59M were sold by MCNAMARA KEVIN J. WILLIAMS DAVID PATRICK also sold $3.16 million worth of Chemed Corporation (NYSE:CHE) on Monday, May 7. The insider Witzeman Michael D sold $313,000. 300 shares valued at $91,476 were sold by Dallob Naomi C on Tuesday, April 24. Shares for $117,485 were sold by SAUNDERS DONALD E.

The stock of Chemed Corporation (NYSE:CHE) hit a new 52-week high and has $341.66 target or 3.00 % above today’s $331.71 share price. The 7 months bullish chart indicates low risk for the $5.29B company. The 1-year high was reported on May, 17 by Barchart.com. If the $341.66 price target is reached, the company will be worth $158.61 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.11% or $0.36 during the last trading session, reaching $331.71. About 13,606 shares traded. Chemed Corporation (NYSE:CHE) has risen 48.33% since May 17, 2017 and is uptrending. It has outperformed by 36.78% the S&P500.

Analysts await Chemed Corporation (NYSE:CHE) to report earnings on July, 24. They expect $2.68 earnings per share, up 24.65 % or $0.53 from last year’s $2.15 per share. CHE’s profit will be $42.72M for 30.94 P/E if the $2.68 EPS becomes a reality. After $2.72 actual earnings per share reported by Chemed Corporation for the previous quarter, Wall Street now forecasts -1.47 % negative EPS growth.

More news for Chemed Corporation (NYSE:CHE) were recently published by: Globenewswire.com, which released: “VITAS HEALTHCARE JOINS AMERICAN HOSPITAL ASSOCIATION” on May 07, 2018. Seekingalpha.com‘s article titled: “Chemed’s (CHE) CEO Kevin McNamara on Q1 2018 Results – Earnings Call Transcript” and published on April 20, 2018 is yet another important article.

Chemed Corporation provides hospice and palliative care services in the United States. The company has market cap of $5.29 billion. It operates through two divisions, VITAS and Roto-Rooter. It has a 56.61 P/E ratio. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Chemed Corporation (NYSE:CHE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: